NCT06981221

Brief Summary

This observational study investigates the predictors of Pleth Variability Index (PVI) changes in euvolemic patients undergoing laparoscopic-assisted vaginal hysterectomy (LAVH). The primary objective is to quantify changes in PVI (ΔPVI) across six intraoperative time points associated with positional shifts. Secondary objectives include identifying key predictors of significant PVI change (ΔPVI ≥ 5%), such as passive leg raising, Trendelenburg position, body mass index (BMI), and intraabdominal pressure. Additional variables including perfusion index, mean arterial pressure, bispectral index, skin temperature, age, and anesthetic agent will be evaluated as potential modulators. Findings aim to support individualized fluid management strategies in LAVH.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2025

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

May 7, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 20, 2025

Completed
Last Updated

May 20, 2025

Status Verified

May 1, 2025

Enrollment Period

29 days

First QC Date

May 7, 2025

Last Update Submit

May 18, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • ΔPVI (Change in Pleth Variability Index)

    Absolute change in PVI (%) at each of six intraoperative time points relative to baseline.

    Intraoperative period (~60-90 minutes)

Secondary Outcomes (8)

  • Proportion of patients with significant ΔPVI ≥ 5%

    At any of the six predefined intraoperative time points: • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg • End of surgery (within 60-90 minutes after induction of anesthesia)

  • Effect of intraabdominal pressure on ΔPVI

    At post-pneumoperitoneum and post-Trendelenburg time points (20-45 minutes after anesthesia induction)

  • Effect of body mass index on ΔPVI

    ΔPVI measured at post-pneumoperitoneum and post-Trendelenburg time points (20-45 minutes after anesthesia induction)

  • Change in mean arterial pressure (MAP)

    MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)

  • Change in perfusion index (PI)

    MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)

  • +3 more secondary outcomes

Interventions

"PVI is continuously monitored using the Masimo Radical-7 pulse oximetry device to evaluate respiratory variation in the plethysmographic waveform amplitude during laparoscopic-assisted vaginal hysterectomy (LAVH). No fluid intervention is applied; device use is for observational measurement of fluid responsiveness."

Also known as: PVI (Pleth Variability Index)

Eligibility Criteria

Age19 Years - 70 Years
Sexfemale
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult female patients aged 19 to 70 years with ASA physical status I-III who are scheduled to undergo elective laparoscopic-assisted vaginal hysterectomy (LAVH) at Wonkwang University Hospital. All participants are screened during routine preoperative consultations and provide written informed consent prior to enrollment.

You may qualify if:

  • adult females aged 19-70 years (American Society of Anesthesiologists physical status I-III) scheduled for elective LAVH.

You may not qualify if:

  • emergency surgery, severe cardiac or pulmonary disease, renal failure, pregnancy, or conditions contraindicating fluid administration. Participants were consecutively recruited during preoperative consultations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wonkwang University School of Medicine Hospital

Iksan, Jeollabuk-do, 54538, South Korea

Location

Study Officials

  • Cheol Lee, M.D.,Ph.D

    Wonkwang University Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 7, 2025

First Posted

May 20, 2025

Study Start

April 1, 2025

Primary Completion

April 30, 2025

Study Completion

May 5, 2025

Last Updated

May 20, 2025

Record last verified: 2025-05

Locations